Clinical Trial Update: Safety of Orectalip® (Oxaliplatin) as Adjuvant Treatment for High-risk Stage-Ⅱ Colorectal Cancer [Phase 4]

View source ↗

Summary

A Phase 4 safety update evaluating Orectalip (oxaliplatin) as adjuvant therapy for high-risk stage II colorectal cancer has completed, reporting safety data fro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Orectalip (Oxaliplatin)

Snippet

Sponsor: Sinphar Pharmaceutical Co., Ltd | Conditions: Stage-Ⅱ Colorectal Cancer | Phase 4 | Status: COMPLETED